Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

ADXN

Addex Therapeutics (ADXN)

Addex Therapeutics Ltd
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ADXN
일자시간출처헤드라인심볼기업
2024/09/1919:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
2024/09/1914:00GlobeNewswire Inc.Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net ProfitNASDAQ:ADXNAddex Therapeutics Ltd
2024/09/0414:00GlobeNewswire Inc.Addex to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
2024/08/2719:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
2024/08/2714:00GlobeNewswire Inc.Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research CollaborationNASDAQ:ADXNAddex Therapeutics Ltd
2024/08/1509:12Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
2024/08/0610:00Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
2024/07/2219:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
2024/07/2214:00GlobeNewswire Inc.Addex’s Partner Discontinues ADX71149 development in EpilepsyNASDAQ:ADXNAddex Therapeutics Ltd
2024/07/1519:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
2024/07/1514:00GlobeNewswire Inc.Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)NASDAQ:ADXNAddex Therapeutics Ltd
2024/07/1214:00GlobeNewswire Inc.Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)NASDAQ:ADXNAddex Therapeutics Ltd
2024/07/0114:00GlobeNewswire Inc.Addex Shareholders Approve All Resolutions at Annual General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
2024/06/0620:29IH Market NewsUS Index Futures Mixed; Oil Prices RiseNASDAQ:ADXNAddex Therapeutics Ltd
2024/06/0619:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
2024/06/0614:00GlobeNewswire Inc.Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
2024/06/0519:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
2024/06/0514:00GlobeNewswire Inc.Addex Convenes Annual General Meeting 2024NASDAQ:ADXNAddex Therapeutics Ltd
2024/05/3114:00GlobeNewswire Inc.Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024NASDAQ:ADXNAddex Therapeutics Ltd
2024/05/0814:00GlobeNewswire Inc.Addex to Present at Bio€quity Europe 2024NASDAQ:ADXNAddex Therapeutics Ltd
2024/04/2914:00GlobeNewswire Inc.Addex Provides Update on ADX71149 Phase 2 Epilepsy StudyNASDAQ:ADXNAddex Therapeutics Ltd
2024/04/1914:00GlobeNewswire Inc.Addex to Present at the Swiss Biotech Day 2024NASDAQ:ADXNAddex Therapeutics Ltd
2024/04/1814:00GlobeNewswire Inc.Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
2024/04/1114:00GlobeNewswire Inc.Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024NASDAQ:ADXNAddex Therapeutics Ltd
2024/04/0314:00GlobeNewswire Inc.Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological DisordersNASDAQ:ADXNAddex Therapeutics Ltd
2024/03/1415:00GlobeNewswire Inc.Addex to Present at the Bio-Europe Spring 2024 ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
2024/01/3115:00GlobeNewswire Inc.Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.NASDAQ:ADXNAddex Therapeutics Ltd
2024/01/3107:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ADXNAddex Therapeutics Ltd
2024/01/3106:58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
2024/01/0915:00GlobeNewswire Inc.Addex to Present at the Swiss Equities Baader ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
 검색 관련기사 보기:NASDAQ:ADXN